Key Architectural Outcomes & Takeaways
- ✓ Algorithmic simulation of 5-tier drug formularies against regional Prescription Drug Plan (PDP) contracts
- ✓ Incorporation of Inflation Reduction Act rules: elimination of catastrophic coinsurance and hard $2,000 annual OOP cap
- ✓ Mathematical modeling of the Medicare Prescription Payment Plan (M3P) monthly smoothing mechanism
- ✓ Automated detection of Step Therapy and Quantity Limit restrictions across competing carrier formularies
1. Overview & Regulatory Shift
Evaluating Medicare Part D prescription coverage requires complex combinatorial math. A single chronic condition (e.g., rheumatoid arthritis, multiple sclerosis, or type 2 diabetes) requiring a specialty medication can swing annual patient costs from 2,000 to over 14,000 between different carrier formularies.
Furthermore, the implementation of the Inflation Reduction Act (IRA) fundamentally restructures Part D cost math:
- Hard
2,000 Out-of-Pocket (OOP) Cap: In 2026, no beneficiary pays more than 2,000 out-of-pocket for covered Part D drugs. - Elimination of Catastrophic 5% Coinsurance: Once reaching catastrophic phase, patient cost is $0.
- Medicare Prescription Payment Plan (M3P): High early deductible costs can be smoothed into equal monthly installments.
This document outlines the architecture for the AskTheHIM Part D Drug Simulation Engine.
2. Formulary Tier Structure
Carriers categorize drugs into five standardized pricing tiers:
| Tier | Classification | Typical Patient Cost Sharing | Carrier Restrictions |
|---|---|---|---|
| Tier 1 | Preferred Generic | 0 – 4 copay | Rare |
| Tier 2 | Generic | 5 – 15 copay | Minimal |
| Tier 3 | Preferred Brand | 35 – 47 copay (or $35 insulin cap) | Step Therapy possible |
| Tier 4 | Non-Preferred Drug | 35% – 50% coinsurance | Prior Authorization common |
| Tier 5 | Specialty Tier | 25% – 33% coinsurance (single-fill > $950) | Mandatory Prior Auth |
3. Mathematical Model of the 2026 Benefit Phases
In 2026, Part D consists of three streamlined benefit phases:
\text{Total Annual Cost} = \sum_{m=1}^{12} P_{\text{premium}} + \min\left(\$2000, \; \sum_{i=1}^{N} C_{\text{patient}}(d_i)\right)Where:
P_{\text{premium}}is the carrier's monthly Part D premium.C_{\text{patient}}(d_i)is the out-of-pocket copay/coinsurance for drugd_i.- Hard Cap: The patient's total drug cost is strictly bounded at
\2,000.00$.
+--------------------------------------------------------------------------+
| 2026 Medicare Part D Benefit Journey |
+--------------------------------------------------------------------------+
Phase 1: Deductible Phase (Up to statutory limit, e.g. $590)
Patient pays 100% of negotiated drug cost until deductible is met.
|
v
Phase 2: Initial Coverage Phase
Patient pays tier copays/coinsurance until cumulative OOP spending reaches $2,000.
|
v
Phase 3: Catastrophic Coverage Phase ($2,000 OOP Cap Achieved)
Patient pays $0.00 for all covered Part D medications for balance of calendar year.
4. Part D Simulation Engine (TypeScript Implementation)
// src/services/medicare/part-d-simulator.ts
export interface Medication {
ndc: string;
name: string;
monthlyRetailCost: number;
tier: 1 | 2 | 3 | 4 | 5;
}
export interface PlanFormularyRules {
planId: string;
planName: string;
monthlyPremium: number;
annualDeductible: number;
tierCopays: {
tier1: number;
tier2: number;
tier3: number;
tier4Coinsurance: number; // e.g. 0.40 for 40%
tier5Coinsurance: number; // e.g. 0.25 for 25%
};
}
export interface AnnualSimulationResult {
planName: string;
totalAnnualPremium: number;
totalOutOfPocketDrugs: number;
totalAnnualCost: number;
monthCapReached?: number;
}
export function simulateAnnualPartDCost(
meds: Medication[],
plan: PlanFormularyRules
): AnnualSimulationResult {
const ANNUAL_OOP_CAP = 2000;
let cumulativeOop = 0;
let remainingDeductible = plan.annualDeductible;
let monthCapReached: number | undefined = undefined;
for (let month = 1; month <= 12; month++) {
for (const med of meds) {
if (cumulativeOop >= ANNUAL_OOP_CAP) {
if (!monthCapReached) monthCapReached = month;
break;
}
let drugCostToPatient = 0;
// 1. Deductible Phase (Tier 1 & 2 often exempt from deductible)
if (remainingDeductible > 0 && med.tier >= 3) {
const deductibleCharge = Math.min(remainingDeductible, med.monthlyRetailCost);
drugCostToPatient += deductibleCharge;
remainingDeductible -= deductibleCharge;
} else {
// 2. Initial Coverage Phase
switch (med.tier) {
case 1: drugCostToPatient = plan.tierCopays.tier1; break;
case 2: drugCostToPatient = plan.tierCopays.tier2; break;
case 3: drugCostToPatient = plan.tierCopays.tier3; break;
case 4: drugCostToPatient = med.monthlyRetailCost * plan.tierCopays.tier4Coinsurance; break;
case 5: drugCostToPatient = med.monthlyRetailCost * plan.tierCopays.tier5Coinsurance; break;
}
}
// Enforce the $2,000 hard ceiling
if (cumulativeOop + drugCostToPatient > ANNUAL_OOP_CAP) {
drugCostToPatient = ANNUAL_OOP_CAP - cumulativeOop;
if (!monthCapReached) monthCapReached = month;
}
cumulativeOop += drugCostToPatient;
}
}
const totalAnnualPremium = plan.monthlyPremium * 12;
return {
planName: plan.planName,
totalAnnualPremium: Math.round(totalAnnualPremium * 100) / 100,
totalOutOfPocketDrugs: Math.round(cumulativeOop * 100) / 100,
totalAnnualCost: Math.round((totalAnnualPremium + cumulativeOop) * 100) / 100,
monthCapReached
};
}
5. Medicare Prescription Payment Plan (M3P) Smoothing Math
Beneficiaries facing $1,500+ in January prescription costs can opt into the M3P program to spread expenses across remaining calendar months without interest:
\text{Monthly Payment}_m = \frac{\text{Remaining Unpaid Incurred Costs} + \text{New Costs}}{13 - m}Where m is the current month index (1 for January, 12 for December).
6. Advisory Verification Checklist
- Verify exact NDC (National Drug Code) numbers to distinguish extended-release (ER) vs immediate-release formulations.
- Check carrier formulary for Prior Authorization (PA) or Step Therapy (ST) restrictions.
- Verify whether insulin medications qualify for the statutory $35/month cap.
- Explain the M3P voluntary opt-in option for seniors facing large Q1 drug copays.
This document was validated against current carrier API specifications, CMS guidelines, and IRS statutes as of November 1, 2026. Consultations with Charles Boyd are complimentary and independent.